106 related articles for article (PubMed ID: 25593840)
1. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study.
Saboo B; Reddy GC; Juneja S; Kedia AK; Manjrekar P; Rathod R;
Indian J Endocrinol Metab; 2015; 19(1):129-35. PubMed ID: 25593840
[TBL] [Abstract][Full Text] [Related]
2. Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.
Philip E; Sundaram ML; Das R; Chauhan SK; Deshpande S; Ambhore S; Rathod R; Manjrekar P
Indian J Endocrinol Metab; 2013 Dec; 17(Suppl 3):S674-9. PubMed ID: 24910836
[TBL] [Abstract][Full Text] [Related]
3. Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes.
Wang JS; Huang CN; Hung YJ; Kwok CF; Sun JH; Pei D; Yang CY; Chen CC; Lin CL; Sheu WH;
Diabetes Res Clin Pract; 2013 Oct; 102(1):16-24. PubMed ID: 23993469
[TBL] [Abstract][Full Text] [Related]
4. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
5. Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.
Joshi SR; Ramachandran A; Chadha M; Chatterjee S; Rathod R; Kalra S
Expert Opin Pharmacother; 2014 Aug; 15(11):1611-20. PubMed ID: 24963542
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
Perez A; Zhao Z; Jacks R; Spanheimer R
Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus.
Ved P; Shah S
Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S110-3. PubMed ID: 22701828
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.
Aashish M; Arindam N; Siddiqi SS; Bhosle D; Mallikarjuna VJ; Amol D; Sanket S; Omkar G; Parth P; Dhruvi H; Durga P; Pradeep D; Suresh K; Vaishali P; Mayura C; Indraneel B; Jayashri S; Arif F; Raghavendra SK; Deepak V; Ravindra T; Shaishav B; Vijay G; Khan K; Mahajani VV; Sharma AD; Mayabhate M; Pawar RR; Aiwale AS; Vinayaka S
Clin Diabetes Endocrinol; 2024 Feb; 10(1):3. PubMed ID: 38336931
[TBL] [Abstract][Full Text] [Related]
9. Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis.
Kalra S; Sahay RK; Schnell O; Sheu WH; Grzeszczak W; Watada H; Soegondo S; Yamamoto N; Weng J; Rathod R
Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S307-9. PubMed ID: 24251196
[TBL] [Abstract][Full Text] [Related]
10. The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population.
Bhattacharjee R; Rai M; Joshi P; Prasad A; Birla A
Cureus; 2023 Oct; 15(10):e46767. PubMed ID: 37954782
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
12. Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study).
Gupta A
Curr Diabetes Rev; 2019; 15(6):510-519. PubMed ID: 31713476
[TBL] [Abstract][Full Text] [Related]
13. International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus.
Li C; Hung YJ; Qamruddin K; Aziz MF; Stein H; Schmidt B
Diabetes Res Clin Pract; 2011 Apr; 92(1):57-64. PubMed ID: 21251726
[TBL] [Abstract][Full Text] [Related]
14. Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study.
Du G; Xie W; Su Y; Ma Y; Gao X; Jiang S; Liang H
PeerJ; 2020; 8():e9905. PubMed ID: 33072435
[TBL] [Abstract][Full Text] [Related]
15. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.
Derosa G; Salvadeo SA; D'Angelo A; Ferrari I; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
Curr Med Res Opin; 2009 Mar; 25(3):607-15. PubMed ID: 19232035
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study.
El Ebrashy I; El Kafrawy N; Raouf R; Yousry D
Diabetes Res Clin Pract; 2020 Apr; 162():108042. PubMed ID: 32006641
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
Kim HS; Kim DM; Cha BS; Park TS; Kim KA; Kim DL; Chung CH; Park JH; Jang HC; Choi DS
J Diabetes Investig; 2014 Nov; 5(6):701-8. PubMed ID: 25422771
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study.
Balaji V
Indian J Endocrinol Metab; 2013 Jul; 17(4):709-15. PubMed ID: 23961491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
